HC Wainwright & Co. Maintains Buy on Precision BioSciences, Adjusts Price Target To $60
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has maintained a Buy rating on Precision BioSciences (NASDAQ:DTIL) and adjusted the price target to $60 from $3.
March 28, 2024 | 2:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. maintains a Buy rating on Precision BioSciences and raises the price target to $60 from $3.
The significant increase in the price target from $3 to $60 by a reputable analyst firm like HC Wainwright & Co. is likely to generate positive investor sentiment and could lead to a short-term increase in the stock price of Precision BioSciences. The maintenance of a Buy rating further reinforces the positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100